{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:31:42Z","timestamp":1780547502735,"version":"3.54.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"name":"Evgenides Foundation"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>While long coronavirus disease 2019 (COVID-19) is linked to prolonged vascular dysfunction in adults, research in children remains poor. In this study, we assessed vascular health in children infected with severe acute respiratory syndrome coronavirus 2 about 6.8 months postinfection, comparing them with healthy controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Two hundred twenty-three children were assessed and divided into group 1, which included children with a positive disease history and group 2, which consisted of healthy controls. Anthropometric measurements, lipid profile, biomarkers (interleukin-6, C-reactive protein, tumor necrosis factor-alpha and soluble intracellular adhesion molecule) and long COVID symptoms were assessed, along with pulse wave velocity (PWV) measurements and carotid intima-media thickness (cIMT) to evaluate aortic stiffness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Children in group 1 were older (mean age: 10.8 \u00b1 3.2 years vs. 8.5 \u00b1 2.8 years, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and had higher body mass index (20.3 \u00b1 5.6\u2009kg\/m<jats:sup>2<\/jats:sup> vs. 18.4 \u00b1 3.5\u2009kg\/m<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). PWV was increased in group 1 (5.02 \u00b1 0.7 m\/s vs. 4.7 \u00b1 0.6, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). However, vascular differences between the groups disappeared after adjusting for age, body mass index, and blood pressure. Soluble intracellular adhesion molecule-1 levels were elevated in children with a history of moderate\/severe COVID-19 infection compared with controls (555.8 \u00b1 113.2\u2009ng\/mL vs. 428 \u00b1 42.6\u2009ng\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Cholesterol levels, inflammatory markers and cIMT were comparable between groups. Long COVID symptoms were reported mainly by participants of group 1 [34 (23.6%) vs. 3 (3.8%), <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This study demonstrates insights into the long-term effects of COVID-19 infection in children. Evidence of endothelial activation without structural arterial changes was found. Persistent inflammation postinfection was absent, yet approximately one-quarter of the participants experienced long COVID symptoms, indicating potential differences in the pathophysiology of postacute COVID-19 infection in childhood.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004786","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:01:58Z","timestamp":1745856118000},"page":"792-797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Long-term Effects of SARS-CoV-2 Infection on Children\u2019s Vasculature"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9993-166X","authenticated-orcid":false,"given":"Dareilena","family":"Karaviti","sequence":"first","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Charakida","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Dimopoulou","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios","family":"Marmarinos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Children\u2019s Hospital \u201cP.& A. Kyriakou,\u201d Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Maritsi","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Spyridis","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaritis","family":"Avgeris","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Children\u2019s Hospital \u201cP.& A. Kyriakou,\u201d Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Gourgiotis","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Children\u2019s Hospital \u201cP.& A. Kyriakou,\u201d Athens, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[{"name":"Second Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"R2-20250723","doi-asserted-by":"crossref","first-page":"1294288","DOI":"10.3389\/fimmu.2023.1294288","article-title":"Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"R4-20250723","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease.","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"key":"R5-20250723","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R6-20250723","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11739-020-02466-1","article-title":"The association between cardiac injury and outcomes in hospitalized patients with COVID-19.","volume":"15","author":"Karbalai Saleh","year":"2020","journal-title":"Intern Emerg Med"},{"key":"R7-20250723","doi-asserted-by":"crossref","first-page":"e008942","DOI":"10.1161\/CIRCOUTCOMES.122.008942","article-title":"Relationship between preexisting cardiovascular disease and death and cardiovascular outcomes in critically ill patients with COVID-19.","volume":"15","author":"Vasbinder","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R8-20250723","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19.","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R9-20250723","doi-asserted-by":"crossref","first-page":"1344086","DOI":"10.3389\/fimmu.2024.1344086","article-title":"The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.","volume":"15","author":"Gheorghita","year":"2024","journal-title":"Front Immunol"},{"key":"R10-20250723","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1093\/eurheartj\/ehaa706","article-title":"Understanding COVID-19: in the end it is the endothelium-what else?","volume":"41","author":"L\u00fcscher","year":"2020","journal-title":"Eur Heart J"},{"key":"R11-20250723","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.10.014","article-title":"Endothelial dysfunction in COVID-19: current findings and therapeutic implications.","volume":"314","author":"N\u00e4gele","year":"2020","journal-title":"Atherosclerosis"},{"key":"R12-20250723","doi-asserted-by":"crossref","first-page":"e13859","DOI":"10.1111\/eci.13859","article-title":"Clinical implications of vascular dysfunction in acute and convalescent COVID-19: a systematic review.","volume":"52","author":"Mavraganis","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"R13-20250723","first-page":"12141","article-title":"Global cardiovascular risk, COVID-19 severity and post-COVID-19 syndrome: a clinical study.","volume":"27","author":"Zaccone","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R14-20250723","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1093\/cid\/ciac661","article-title":"Coronavirus disease 2019 severity and risk of subsequent cardiovascular events.","volume":"76","author":"Wiemken","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R15-20250723","doi-asserted-by":"crossref","first-page":"1268571","DOI":"10.3389\/fcvm.2024.1268571","article-title":"Beyond acute infection: molecular mechanisms underpinning cardiovascular complications in long COVID.","volume":"11","author":"Mostafa","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R16-20250723","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ajh\/hpv048","article-title":"Aortic pulse wave velocity in healthy children and adolescents: reference values for the vicorder device and modifying factors.","volume":"28","author":"Thurn","year":"2015","journal-title":"Am J Hypertens"},{"key":"R17-20250723","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-77932-4_10","article-title":"Arterial flow, pulse pressure and pulse wave velocity in men and women at various ages.","volume":"1065","author":"Avolio","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"R18-20250723","first-page":"3","article-title":"Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors.","volume":"6","author":"Espeland","year":"2005","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"R19-20250723","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19.","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"R20-20250723","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications.","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ Res"},{"key":"R21-20250723","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy.","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"R22-20250723","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed.","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R23-20250723","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","article-title":"Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.","volume":"44","author":"Xu","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"R24-20250723","first-page":"781","article-title":"Acute and long-term consequences of COVID-19 on arterial stiffness-a narrative review.","volume":"12","author":"Zota","year":"2022","journal-title":"Life (Basel)"},{"key":"R25-20250723","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/ejhf.2326","article-title":"Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection.","volume":"23","author":"Lambadiari","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"R26-20250723","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCRESAHA.121.320460","article-title":"Vascular dysfunction of COVID-19 is partially reverted in the long-term.","volume":"130","author":"Zanoli","year":"2022","journal-title":"Circ Res"},{"key":"R27-20250723","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/HYPERTENSIONAHA.122.19958","article-title":"Sympathetic neural overdrive, aortic stiffening, endothelial dysfunction, and impaired exercise capacity in severe COVID-19 survivors: a mid-term study of cardiovascular sequelae.","volume":"80","author":"Faria","year":"2023","journal-title":"Hypertension"},{"key":"R28-20250723","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ejhf.2451","article-title":"Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection.","volume":"24","author":"Ikonomidis","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R29-20250723","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00380-022-02180-2","article-title":"Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation.","volume":"38","author":"Oikonomou","year":"2023","journal-title":"Heart Vessels"},{"key":"R30-20250723","first-page":"1","article-title":"Evaluation of endothelial dysfunction and inflammatory vasculopathy after SARS-CoV-2 infection\u2014a cross-sectional study.","volume":"8","author":"Jud","year":"2021","journal-title":"Front Cardiovascr Med"},{"key":"R31-20250723","doi-asserted-by":"crossref","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","article-title":"Biomarkers in long COVID-19: a systematic review.","volume":"10","author":"Lai","year":"2023","journal-title":"Front Med (Lausanne)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T20:00:25Z","timestamp":1753300825000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004786","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}